FANCM-BTR PPI-IN-1
Selected Variant
HY-163573-01
Size: 5 mg
FANCM-BTR PPI-IN-1 (Comp 32) is a disruptor of the FANCM/ BTR interaction which hampers the FANCM localization to telomeres. FANCM-BTR PPI-IN-1 can be used for cancer research[1].
Product Specifications
CAS Number
3033990-61-0
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fancm-btr-ppi-in-1.html
Purity
98.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(NCC2=CN=CN2)C=C1)(N(C3CCCC3)CC4=CC=C5C(CCCN5CC)=C4)=O
Molecular Formula
C27H35N5O2S
Molecular Weight
493.66
References & Citations
[1]Sandro C, et al. Tetrahydroquinoline compounds as antitumor agents. WO2024068467A1. 2024-04-04
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM1993-50 1x 50 µL
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1993), 1mg/mL
Sign In for Pricing
View Details 
BNC683005-100 1x 100 µL
ER-beta-1 (Estrogen Receptor beta-1) (ESR2/3005), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
A04180-1-HRP 100 µg/Vial
Anti-MT-ND4 Antibody Picoband®, HRP Conjugate
Sign In for Pricing
View Details 
BNC401200-500 1x 500 µL
EGFR (GFR1195 + 31G7), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details